Cargando…
Circulating Cell-Free DNA as a Prognostic and Molecular Marker for Patients with Brain Tumors under Perillyl Alcohol-Based Therapy
Tumor infiltration into brain tissue usually remains undetected even by high-resolution imaging. Molecular markers are used to increase diagnostic accuracy, but with limited continuous monitoring application. We evaluated the potential of circulating cell-free DNA (cfDNA) as a molecular indicator of...
Autores principales: | Faria, Giselle, Silva, Emanuelle, Da Fonseca, Clovis, Quirico-Santos, Thereza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6032335/ https://www.ncbi.nlm.nih.gov/pubmed/29848970 http://dx.doi.org/10.3390/ijms19061610 |
Ejemplares similares
-
Ras pathway activation in gliomas: a strategic target for intranasal administration of perillyl alcohol
por: Fonseca, Clovis Orlando da, et al.
Publicado: (2008) -
Adjuvant effect of low-carbohydrate diet on outcomes of patients with recurrent glioblastoma under intranasal perillyl alcohol therapy
por: Santos, Juliana Guimaraes, et al.
Publicado: (2020) -
Intranasal perillyl alcohol therapy improves survival of patients with recurrent glioblastoma harboring mutant variant for MTHFR rs1801133 polymorphism
por: Faria, Giselle M., et al.
Publicado: (2020) -
Perillyl alcohol: Dynamic interactions with the lipid bilayer and implications for long-term inhalational chemotherapy for gliomas
por: da Fonseca, Clovis Orlando, et al.
Publicado: (2016) -
Intranasal Perillyl Alcohol for Glioma Therapy: Molecular Mechanisms and Clinical Development
por: Chen, Thomas C., et al.
Publicado: (2018)